Fecal microbiota therapy in recurrent and refractory clostridium difficile infections has been associated with positive results in immunocompromised patients

Abstract

A critical appraisal and clinical application of Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. The American Journal of Gastroenterology, 2014;109(7):1065-71. doi: 10.1038/ajg.2014.133